Analysis from the Women's Health Initiative has found that women who took the bone saving drugs called bisphosphonates had fewer invasive breast cancers than women who didn't take the meds. The analysis of more than 150,000 women found that those who were taking Fosamax had 32 percent fewer cases of invasive breast cancer. Experts say further studies are needed, but they suggest that the finding may affect a woman's decision about whether she takes a bisphosphonate or not.
Researchers at the University of Wisconisn are trying to tweak the Vitamin D molecule to develop a new medication against osteoporosis that... Read more »
Are you one of the many taking bisphosphonates to treat your osteoporosis? Researchers recently found that taking a smaller dose, than... Read more »
The osteoporosis medication Forteo appears to help bone fractures heal more quickly, researchers say. Researchers gave the drug to 145 people who had... Read more »
About half of the patients prescribed osteoporosis medications stop taking them within six months, a new report has found. This statistic was true... Read more »
Two recent studies have found that the osteoporosis drug Forteo (teriparatide) may help regrow bone in people who have lost bone because of... Read more »
According to a press release from drugmaker Novartis, the European Union has approved the one-a-year osteoporosis drug Reclast for use in men who are... Read more »
The U.S. Food and Drug Administration (FDA) says there are no heart rhythm problems associated with some osteoporosis medications. The conclusion was... Read more »